MediPoint: Total Wrist Reconstruction - EU Analysis and Market Forecasts

NEW YORK, April 16, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Total Wrist Reconstruction - EU Analysis and Market Forecasts

http://www.reportlinker.com/p01158482/MediPoint-Total-Wrist-Reconstruction---EU-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

MediPoint: Total Wrist Reconstruction - EU Analysis and Market Forecasts

Summary

Injuries to any of the bones, ligaments, tendons or nerves in the wrist joint can cause pain. Severe arthritis is the most common condition for patients considering a total wrist replacement surgery. Two major categories of arthritis may affect the wrist joint, namely osteoarthritis and rheumatoid or inflammatory arthritis. Post traumatic arthritis is another reason for the onset of osteoarthritis years later after trauma to the joint. Finally another indication for wrist pain and dysfunction includes carpal tunnel syndrome.

The growth rate is moderate for the adoption rate of these devices and will be due to a slow and gradual adoption rate, with the EU behind only the US in leading the way.

Scope

- An overview of arthritis, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized EU TWR market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for TWR
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the TWR device sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as orthopedists

Reasons to buy

- Understand the trends shaping and driving the EU TWR Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the EU TWR Market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in EU TWR market landscape? Identify, understand and capitalize.

Table of Contents

1 Table of Contents 6
1.1 List of Tables 12
1.2 List of Figures 14
2 Introduction 15
2.1 Catalyst 15
3 Disease Overview 16
3.1 Anatomy and Physiology 16
3.2 Pathophysiology 17
3.2.1 Overview 17
3.2.2 Osteoarthritis 17
3.2.3 Rheumatoid Arthritis 18
3.2.4 Carpal Tunnel Syndrome 18
3.2.5 Others 18
3.3 Clinical Presentation 19
3.4 Clinical Outcomes 20
3.4.1 Overview 20
3.4.2 Conservative Therapy 21
3.4.3 Arthroscopic Debridement 21
3.4.4 Proximal Row Carpectomy 21
3.4.5 Total Wrist Fusion 22
3.4.6 Total Wrist Replacement 24
3.4.7 Wrist Fusion Versus Total Wrist Replacement 26
3.5 Epidemiology 27
3.6 Economic Impact 29
3.6.1 Economic Impact of Treating Arthritis 29
3.6.2 Cost Effectiveness of Orthopedic Implants 30
4 Competitive Assessment 31
4.1 Total Wrist Implant 31
4.1.1 Overview of Historical Designs 31
4.1.2 Current Designs 31
4.2 Total Wrist Fusion 43
4.2.1 Overview of Historical Designs 43
4.2.2 Current Designs 43
5 Unmet Needs 51
5.1 Long-Term Clinical Data 51
5.2 Limited Product Offerings 52
5.3 Failure and Revision Rate 53
5.4 Minimal Bone Resection and Other Complications 53
5.5 Lack of Pipeline Products 55
5.6 Need for Better Physician Training 55
6 Pipeline Products 57
6.1 Overview 57
7 Industry Overview 58
7.1 Procedure Volumes 58
7.1.1 Europe 59
7.2 Market Access 61
7.2.1 Europe 62
7.3 Reimbursement Trends 63
7.3.1 Europe 63
7.4 Regulatory Issues/Recalls 66
7.5 Mergers & Acquisitions / Key Partnerships 66
8 Company Profiles 69
8.1 Small Bone Innovation Inc. 69
8.1.1 Overview 69
8.1.2 Portfolio Assessment 69
8.1.3 SWOT Analysis 70
8.2 Depuy Synthes International 70
8.2.1 Overview 70
8.2.2 Portfolio Assessment 70
8.2.3 SWOT Analysis 71
8.3 Integra LifeSciences Inc. 72
8.3.1 Overview 72
8.3.2 Portfolio Assessment 72
8.3.3 SWOT Analysis 72
8.4 Biomet Orthopedics 73
8.4.1 Overview 73
8.4.2 Portfolio Assessment 73
8.4.3 SWOT Analysis 74
8.5 Medartis AG 74
8.5.1 Overview 74
8.5.2 Portfolio Assessment 74
8.5.3 SWOT Analysis 75
8.6 Acumed 75
8.6.1 Overview 75
8.6.2 Portfolio Assessment 75
8.6.3 SWOT Analysis 76
8.7 Tornier N.V. 77
8.7.1 Overview 77
8.7.2 Portfolio Assessment 77
8.7.3 SWOT Analysis 78
8.8 Swemac Orthopaedics AB 78
8.8.1 Overview 78
8.8.2 Portfolio Assessment 78
8.8.3 SWOT Analysis 79
8.9 Zimmer Holdings Inc. 79
8.9.1 Overview 79
8.9.2 Portfolio Assessment 79
8.9.3 SWOT Analysis 80
8.10 Skeletal Dynamics 81
8.10.1 Overview 81
8.10.2 Portfolio Assessment 81
8.10.3 SWOT Analysis 81
9 Market Drivers & Opportunities 82
9.1 Market Drivers 82
9.1.1 Rise in Osteoarthritis 82
9.1.2 Aging 82
9.1.3 Trauma 82
9.1.4 Patient Demand and Awareness 83
9.1.5 Availability of Long-Term Clinical Data 83
9.1.6 Further Technological Advancement 84
9.1.7 Corporate Promotions and Teaching Seminars 84
9.2 Opportunities 85
9.2.1 Expanding Aging and Arthritis Indication 85
9.2.2 Revision Surgery 85
9.2.3 Emerging Markets 86
9.2.4 Capitalizing on Market Fragmentation 86
10 Market Threats & Substitutes 87
10.1 Market Threats 87
10.1.1 Slow Technological Advancement 87
10.1.2 Physician Perception and Learning Curve 87
10.1.3 Complications 88
10.1.4 Cost 88
10.1.5 Lack of Long-Term Studies 89
10.2 Substitutes 89
10.2.1 Therapeutic Options and Fusion 89
11 Country Outlooks & Forecasts 90
11.1 EU Markets Overview 90
11.2 France 94
11.2.1 Overview 94
11.2.2 France Market Analysis 94
11.3 Germany 95
11.3.1 Overview 95
11.3.2 Germany Market Analysis 95
11.4 Italy 97
11.4.1 Overview 97
11.4.2 Italy Market Analysis 97
11.5 Spain 98
11.5.1 Overview 98
11.5.2 Spain Market Analysis 98
11.6 UK 99
11.6.1 Overview 99
11.6.2 UK Market Analysis 99
12 Appendix 101
12.1 Abbreviations 101
12.2 Bibliography 102
12.3 Report Methodology 108
12.3.1 Overview 108
12.3.2 Coverage 108
12.3.3 Secondary Research 108
12.3.4 Forecasting Methodology 109
12.3.5 Primary Research – Key Opinion Leader Interviews 110
12.3.6 Primary Research – Physician Survey 110
12.3.7 Expert Panel Validation 110
12.4 Physicians and Specialists Included in this Study 111
12.4.1 Dr. Philippe Bellemère 111
12.4.2 Dr. Vikas Gupta, MBBS, MS 111
12.4.3 William H. Seitz, Jr., MD 111
12.4.4 Robert M. Szabo, MD, MPH 111
12.4.5 David Warwick, MD, BM, DIMC, FRCS (Orth) 111
12.5 About the Authors 112
12.5.1 Analysts 112
12.5.2 Global Head of Healthcare 113
12.6 About MediPoint 113
12.7 About GlobalData 113
12.8 Contact Us 114
12.9 Disclaimer 114

List of Tables

Table 1: Clinical Symptoms and Descriptions 19
Table 2: Advantages and Disadvantages of Wrist Fusion and Total Wrist Replacement 27
Table 3: Direct and Indirect Costs of Arthritis 29
Table 4: Universal 2 Total Wrist Implant System (Integra LifeSciences Inc.) 33
Table 5: SWOT Universal 2 Total Wrist Implant System 33
Table 6: ReMotion Total Wrist (Small Bone Innovations, Inc.) 34
Table 7: SWOT ReMotion Total Wrist 35
Table 8: Maestro Total Wrist System (Biomet Orthopedics) 36
Table 9: SWOT Maestro Total Wrist System 36
Table 10: Tornier Resurfacing Capitate Pyrocarbon Implant 38
Table 11: SWOT:Tornier Resurfacing Capitate Pyrocarbon Wrist Implant 38
Table 12: Motec Wrist Joint Prosthesis (Swemac Orthopaedics AB) 40
Table 13: SWOT Motec Wrist Joint Prosthesis 41
Table 14: MWP III Total Wrist Prosthesis (Zimmer Inc.) 42
Table 15: SWOT MWP III Total Wrist Prosthesis 43
Table 16: LCP Wrist Fusion Set (DePuy Synthes, Johnson & Johnson Co.) 45
Table 17: SWOT LCP Wrist Fusion Set 45
Table 18: Integra Total Wrist Fusion System (Integra LifeSciences Inc.) 46
Table 19: SWOT Integra Total Wrist Fusion System 47
Table 20: Arthrodesis System 2.0/2.3, 2.5 APTUS Wrist (Medartis AG) 48
Table 21: SWOT Arthrodesis System 2.0/2.3, 2.5 APTUS Wrist 48
Table 22: Arthrodesis System 2.0/2.3, 2.5 APTUS Wrist (Medartis AG) 49
Table 23: SWOT Implate Wrist Arthrodesis Nail 50
Table 24: Complications and Risks for TWR and TWF 54
Table 25: Product Components and Costs 61
Table 26: Regulatory Differences Between the US and EU 62
Table 27: Company Profile – Small Bone Innovation Inc. 69
Table 28: SWOT Analysis – Small Bone Innovations Inc. 70
Table 29: Company Profile – Depuy Synthes International 71
Table 30: SWOT Analysis – Depuy Synthes International 71
Table 31: Company Profile – Integra LifeSciences Inc. 72
Table 32: SWOT Analysis – Integra LifeSciences Inc. 72
Table 33: Company Profile – Biomet Orthopedics 73
Table 34: SWOT Analysis – Biomet Orthopedics 74
Table 35: Company Profile – Medartis AG 74
Table 36: SWOT Analysis – Medartis AG 75
Table 37: Company Profile – Acumed LLC 76
Table 38: SWOT Analysis – Acumed LLC 76
Table 39: Company Profile – Tornier N.V. 77
Table 40: SWOT Analysis – Tornier N.V. 78
Table 41: Company Profile – Swemac Orthopaedics AB 79
Table 42: SWOT Analysis – Swemac Orthopaedics AB 79
Table 43: Company Profile – Zimmer Holdings Inc. 80
Table 44: SWOT Analysis – Zimmer Holdings, Inc. 80
Table 45: Company Profile – Skeletal Dynamics LLC 81
Table 46: SWOT Analysis – Skeletal Dynamics LLC 81
Table 47: EU Sales ($m) Forecast for TWF and TWR, 2009–2018 90
Table 48: France Sales ($m) Forecast for TWF and TWR, 2009–2018 94
Table 49: Germany Sales ($m) Forecast for TWF and TWR, 2009–2018 96
Table 50: Italy Sales ($m) Forecast for TWF and TWR, 2009–2018 97
Table 51: Spain Sales ($m) Forecast for TWF and TWR, 2009–2018 98
Table 52: UK Sales ($m) Forecast for TWF and TWR, 2009–2018 100

List of Figures

Figure 1: Anatomy of the Wrist 16
Figure 2: Treatment Paradigm for Wrist Arthritis 20
Figure 3: Wrist Arthrodesis with a Fusion Plate 23
Figure 4: Total Wrist Arthroplasty 25
Figure 5: Population with Wrist Arthritis in Major Markets, 2009–2018 28
Figure 6: Disease Segments of Wrist Arthritis 29
Figure 7: Universal 2 Total Wrist Implant System (Integra LifeSciences Inc.) 32
Figure 8: ReMotion Total Wrist (Small Bone Innovations, Inc.) 34
Figure 9: Maestro Total Wrist System (Biomet Orthopedics) 35
Figure 10: Tornier Resurfacing Capitate Pyrocarbon Implant 37
Figure 11: Motec Wrist Joint Prosthesis (Swemac Orthopaedics AB) 40
Figure 12: MWP III Total Wrist Prosthesis (Zimmer Inc.) 42
Figure 13: LCP Wrist Fusion Set (DePuy Synthes, Johnson & Johnson Co.) 44
Figure 14: Integra Total Wrist Fusion System (Integra LifeSciences Inc.) 46
Figure 15: Arthrodesis System 2.0/2.3, 2.5 APTUS Wrist (Medartis AG) 47
Figure 16: Implate Wrist Arthrodesis Nail (Skeletal Dynamics LLC) 49
Figure 17: Importance of Safety of Arthrodesis and Arthroplasty Implants 54
Figure 18: Europe Arthrodesis and Arthroplasty Procedure Volumes (2009–2018) 60
Figure 19: EU Sales ($m) Forecast for TWR and TWF, 2009–2018 91
Figure 20: TWR Revenue by EU Market, 2009 and 2018 92
Figure 21: TWF Revenue by EU Market, 2009 and 2018 93
Figure 22: France TWR and TWF Market, 2009–2018 95
Figure 23: Germany TWR and TWF Market, 2009–2018 96
Figure 24: Italy TWR and TWF Market, 2009–2018 97
Figure 25: Spain TWR and TWF Market, 2009–2018 98
Figure 26: UK TWR and TWF Market, 2009–2018 100

Companies Mentioned

Small Bone Innovation Inc.
Depuy Synthes International
Integra LifeSciences Inc.
Biomet Orthopedics
Medartis AG
Acumed
Tornier N.V.
Swemac Orthopaedics AB
Zimmer Holdings Inc.
Skeletal Dynamics

To order this report:
Orthopedic Industry: MediPoint: Total Wrist Reconstruction - EU Analysis and Market Forecasts

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker